An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Here, Hanke et al. immunize an alpaca with SARS-CoV-2 spike protein domains and identify a nanobody that binds the receptor binding domain of spike in both the up and down conformations and sterically hinders ACE2 engagement.
Guardado en:
Autores principales: | Leo Hanke, Laura Vidakovics Perez, Daniel J. Sheward, Hrishikesh Das, Tim Schulte, Ainhoa Moliner-Morro, Martin Corcoran, Adnane Achour, Gunilla B. Karlsson Hedestam, B. Martin Hällberg, Ben Murrell, Gerald M. McInerney |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d6d86e0a27242f592c4fcf292d06534 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
por: Tânia F. Custódio, et al.
Publicado: (2020) -
Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models
por: Daniel J. Sheward, et al.
Publicado: (2021) -
Production of individualized V gene databases reveals high levels of immunoglobulin genetic diversity
por: Martin M. Corcoran, et al.
Publicado: (2016) -
Evaluation of antidiphtheria toxin nanobodies
por: Ghada H Shaker
Publicado: (2010) -
Farmacocinética de la ampicilina en Alpacas (Lama pacos )
por: KREIL,V, et al.
Publicado: (2001)